Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.0.1450645
European Journal of Endocrinology, Vol 145, Issue 5, 645-650
Copyright © 2001 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Di Matola, T
Right arrow Articles by Vitale, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Di Matola, T
Right arrow Articles by Vitale, M
Articles

Lovastatin-induced apoptosis in thyroid cells: involvement of cytochrome c and lamin B

T Di Matola, F D'Ascoli, C Luongo, M Bifulco, G Rossi, G Fenzi, and M Vitale

Dipartimento di Biologia e Patologia Cellulare e Molecolare, Universita Federico II, Via S Pansini 5, 80131, Naples, Italy.

OBJECTIVE: The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, lovastatin, induces apoptosis in the thyroid cell line TAD-2 and in proliferating normal human thyroid cells in culture, through a p53-independent mechanism involving caspase-3-like proteases. The combination of lovastatin with other anti-neoplastic drugs potentiates chemotherapy of tumors. This drug has been suggested for the chemotherapy of tumors and is potentially useful in the treatment of thyroid proliferative diseases. Based on this premise, we analyzed in more detail the role of some molecular effectors and the role of the caspase family proteases in the lovastatin-induced apoptotic pathway in TAD-2 cells. METHODS: TAD-2 cells were treated with lovastatin to induce apoptosis, and expression of p53, Bc1-2, Bcl-XL and Bax was analyzed by Western blot. Caspase activation was evaluated by the assay of enzymatic activity with chromogenic peptides and Western blot. Nuclear, cytosolic and mitochondrial fractions were prepared by differential centrifugation and the presence of cytochrome c and lamin B was evaluated by Western blot. RESULTS: p53, Bc1-2, Bcl-XL and Bax protein expression were unchanged during apoptosis. Cytochrome c was released from mitochondria into the cytosol, a pivotal event in the activation of caspase-3. Caspase-3 and -6 but not caspase-2 were activated, and proteolysis of PARP and lamin B, a caspase-6 substrate located in the inner nuclear membrane, was demonstrated by Western blot. The nuclear localization of lamin B was also inhibited by lovastatin. CONCLUSIONS: These data demonstrate that, in TAD-2 thyroid cells, lovastatin induces lamin B proteolysis and inhibits its nuclear localization and induces cytochrome c release from mitochondria into the cytosol.


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
S. Gullu, R. Emral, M. Bastemir, A. B Parkes, and J. H Lazarus
In vivo and in vitro effects of statins on lymphocytes in patients with Hashimoto's thyroiditis
Eur. J. Endocrinol., July 1, 2005; 153(1): 41 - 48.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M.-A. Shibata, Y. Ito, J. Morimoto, and Y. Otsuki
Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism
Carcinogenesis, October 1, 2004; 25(10): 1887 - 1898.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W.-B. Zhong, C.-Y. Wang, T.-C. Chang, and W.-S. Lee
Lovastatin Induces Apoptosis of Anaplastic Thyroid Cancer Cells via Inhibition of Protein Geranylgeranylation and de Novo Protein Synthesis
Endocrinology, September 1, 2003; 144(9): 3852 - 3859.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 European Society of Endocrinology.